Group B Streptococcus early-onset disease and observation of well-appearing newborns
Open Access
- 20 March 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (3) , e0212784
Abstract
International guidelines lack a substantial consensus regarding management of asymptomatic full-term and late preterm neonates at risk for early-onset disease (EOS). Large cohorts of newborns are suitable to increase the understanding of the safety and efficacy of a given strategy. This is a prospective, area-based, cohort study involving regional birth facilities of Emilia-Romagna (Italy). We compared cases of EOS (at or above 35 weeks’ gestation) registered in 2003–2009 (baseline period: 266,646 LBs) and in 2010–2016, after introduction of a new strategy (serial physical examinations, SPEs) for managing asymptomatic neonates at risk for EOS (intervention period: 265,508 LBs). There were 108 cases of EOS (baseline period, n = 60; intervention period, n = 48). Twenty-two (20.4%) remained asymptomatic through the first 72 hours of life, whereas 86 (79.6%) developed symptoms, in most cases (52/86, 60.5%) at birth or within 6 hours. The median age at presentation was significantly earlier in the intrapartum antibiotic prophylaxis (IAP)-exposed than in the IAP-unexposed neonates (0 hours, IQR 0.0000–0.0000 vs 6 hours, IQR 0.0000–15.0000, pvs 33%, p = 0.01), age at presentation decreased (median 6 vs 1 hours, p = 0.01), whereas meningitis, mechanical ventilation and mortality did not change in baseline vs intervention period. After implementing the SPEs, no cases had adverse outcomes due to the strategy, and no cases developed severe disease after 6 hours of life. Infants with EOS exposed to IAP developed symptoms at birth in almost all cases, and those who appeared well at birth had a very low chance of having EOS. The risk of EOS in neonates (asymptomatic at birth) exposed to intrapartum fever was low. Although definite conclusions on causation are lacking, our data support SPEs of asymptomatic newborns at risk for EOS. SPEs seems a safe and effective alternative to laboratory screening and empirical antibiotic therapy.Keywords
This publication has 21 references indexed in Scilit:
- Recognising early onset neonatal sepsis: an essential step in appropriate antimicrobial useJournal of Infection, 2016
- The burden of early-onset sepsis in Emilia-Romagna (Italy): a 4-year, population-based studyThe Journal of Maternal-Fetal & Neonatal Medicine, 2016
- Chorioamnionitis and Culture-Confirmed, Early-Onset Neonatal InfectionsPediatrics, 2016
- Reappraisal of Guidelines for Management of Neonates with Suspected Early-Onset SepsisThe Journal of Pediatrics, 2015
- Safety of physical examination alone for managing well-appearing neonates ≥35 weeks’ gestation at risk for early-onset sepsisThe Journal of Maternal-Fetal & Neonatal Medicine, 2014
- Recommendations for term and late preterm infants at risk for perinatal bacterial infectionSwiss Medical Weekly, 2013
- Impact of Perinatal Practices for Early-onset Group B Streptococcal Disease PreventionThe Pediatric Infectious Disease Journal, 2013
- Limitations of the risk factor based approach in early neonatal sepsis evaluationsActa Paediatrica, 2012
- Early-Onset Group B Streptococcal Disease in the Era of Maternal ScreeningObstetrical & Gynecological Survey, 2005
- Early-Onset Group B Streptococcal Disease in the Era of Maternal ScreeningPediatrics, 2005